Exclusive: Insitro makes headway on the harder road, discovering new ALS drug target

The AI-focused biotech insitro is advancing a new idea to potentially treat ALS, one of the most intractable and brutal diseases.

The South San Francisco …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Respiratory Syncytial Virus (RSV) Infections drugs in development, 2023

GlobalData tracks 184 drugs in development for Respiratory Syncytial Virus (RSV) Infections by 144 companies/universities/institutes. The top development phase for Respiratory Syncytial Virus (RSV) Infections

December 1, 2023

FDA warns providers on Getinge devices tied to 17 serious injuries

Dive Brief: The Food and Drug Administration alerted healthcare providers Friday about the safety and supply of Getinge/Maquet vessel harvesting devices. The letter to providers

November 18, 2024

Women with endometriosis have more contact with healthcare providers in the years prior to diagnosis

Beginning as far back as ten years before even being diagnosed, women with endometriosis utilise the healthcare system more than women without this chronic illness.

August 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.